Samsung and Chung-Ang University Gwangmyeong Hospital have validated a breakthrough method for predicting vasovagal syncope (VVS) using the Galaxy Watch6. The joint study represents the first time a commercial smartwatch has demonstrated the capacity to provide early warnings for syncope.
The 5-Minute Warning
By analyzing biosignals through the watch’s photoplethysmography (PPG) sensor, a specialized AI algorithm identifies impending fainting episodes before they occur.
- Prediction Window: The system can alert users up to five minutes before a loss of consciousness.
- Accuracy Metrics: The model achieved 84.6% accuracy, with a sensitivity of 90% and a specificity of 64%.
- Methodology: Researchers evaluated 132 patients during induced fainting tests, focusing on Heart Rate Variability (HRV) data.
Preventing Secondary Injury
Vasovagal syncope occurs when heart rate and blood pressure drop abruptly, often triggered by stress. While the fainting itself is rarely fatal, the resulting falls frequently cause fractures or concussions.
- Prevalence: Approximately 40% of people experience VVS in their lifetime.
- Recurrence: One-third of those who faint once will suffer from recurrent episodes.
- Safety Window: A five-minute lead time allows patients to reach a safe position (sitting or lying down) or call for assistance, significantly reducing the risk of trauma.
Shift to Preventive Care
The study reveals a shift in wearable tech from post-care monitoring to preventive healthcare.
Samsung plans to use these insights to enhance personalized health features across its wearable lineup, including the Galaxy Watch8 and Watch8 Classic.
